Jody A. Charnow, Editor, Author at Renal and Urology News

Jody A. Charnow, Editor

All articles by Jody A. Charnow, Editor

Review for Preventive Kidney Injury Therapy

SR Pharma PLC, of London, announced that the FDA has accepted its Investigational New Drug application (IND) for AKIi-5, a small interfering RNA (siRNA) therapeutic for the prevention of acute kidney injury (AKI) in high-risk patients undergoing major cardiovascular surgery.

Immunotherapy for Prostate Cancer Endorsed

FDA’s Office of Cellular, Tissue and Gene Therapies Advisory Committee recommended to the agency that there is substantial evidence of efficacy and safety of Provenge (sipuleucel-T), made by Dendreon Corporation of Seattle, for treating patients with hormone refractory prostate cancer.

Early Zoledronic Acid Use Beneficial

Treatment with zoledronic acid (Zometa) before onset of skeletal morbidity may lower the risk of skeletal-related events (SRE) and prolong the time to the first SRE in men with bone metastases from prostate cancer, according to German researchers.

Next post in News